CANF · Can-Fite BioPharma Ltd.
Market Cap
$6.81M
Shares
2.14M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$9.83M
-24.7%
FY2025
Diluted EPS
-$5.97
+45%
FY2025
Operating Cash Flow
-$8.95M
-17.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | -$77K | $227K | -$304K | -$618K | -$1.15M | — | — | — | |
| $6.69M | $5.76M | $5.98M | $7.76M | $9.85M | $11.95M | $10.98M | $6.08M | $5.11M | $6.12M | $3.9M | |
| $3.66M | $3.05M | $2.96M | $3.14M | $3.85M | $2.95M | $3.06M | $3.16M | $2.87M | $2.73M | $2.74M | |
| — | — | — | $263K | $466K | $317K | — | — | — | — | — | |
| $24K | $7000 | $15K | $14K | $14K | $12K | $14K | $14K | $3000 | $4000 | $4000 | |
| $10.36M | $8.8M | $8.94M | $10.91M | — | — | — | — | — | — | — | |
| -$9.95M | -$8.13M | -$8.2M | -$10.1M | -$12.84M | -$14.14M | -$12.01M | -$5.41M | -$7.19M | -$8.68M | -$6.48M | |
| $284K | $291K | $506K | -$222K | — | — | $693K | $1.2M | $621K | $55K | -$133K | |
| $122K | $250K | $561K | -$77K | $227K | -$304K | -$618K | -$1.15M | $1.6M | — | — | |
| — | — | — | — | $162K | $11K | — | — | — | — | — | |
| -$9.83M | -$7.88M | -$7.63M | -$10.17M | -$12.62M | -$14.44M | -$12.63M | -$6.57M | -$6.4M | -$8.36M | -$6.5M | |
| — | — | — | — | — | — | — | $4000 | $29K | $29K | $5000 | |
| -$9.83M | -$7.88M | -$7.63M | -$10.17M | -$12.62M | -$14.44M | -$12.63M | -$6.57M | -$6.34M | $8.26M | $6.24M | |
| — | -$7.88M | -$7.63M | -$10.17M | — | — | -$12.63M | -$6.57M | -$4.21M | — | — | |
| USD/shares | -$5.97 | -$10.86 | -$17.92 | -$0.20 | -$0.60 | -$0.80 | — | — | — | — | — |
| USD/shares | -$5.97 | -$10.86 | -$17.92 | -$0.20 | -$0.60 | -$0.80 | — | — | — | — | — |
| shares | 1.65M | 725.31K | 426.11K | 40.79M | 27.65M | 17.92M | 429.55K | 194.51K | 162.63K | — | — |
| shares | 1.65M | 725.31K | 426.11K | 40.79M | 27.65M | 17.92M | 429.55K | 194.51K | 162.63K | — | — |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2020–FY2021: $3.31M in dividends.